-
Markets rally on coronavirus drug report
-
Final European CPI reading for March
-
Procter & Gamble to report earnings ahead of opening bell
Moods on the global markets are improving with more and more countries outlining steps to reopen economies. Reports saying that a coronavirus drug developed by Gilead Science (GILD.US) is also doing its part. Simultaneously, markets are ignoring disastrous GDP data from China. DAX is expected to open around 300 pts above yesterday's close. There are no data releases scheduled for today that could turn to be major market movers so traders should focus on newsflow and earnings. Schlumberger, the US oil services company, will release a report ahead of the US session open and it may offer important insight into the situation in the oil sector.
10:00 am BST - Euro area, CPI inflation for March (final). Preliminary release: 0.7%
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile app3:00 pm BST - US, leading index for March. Expected: -7%. Previous: 0.1%
6:00 pm BST - Baker Hughes US oil rig count. Last week: 504
Central bankers' speeches
-
2:00 pm BST - Fed's Bullard
-
2:00 pm BST - ECB's Rehn
Noteworthy earnings releases
-
Procter & Gamble (PG.US) - before market opens
-
Schlumberger (SLB.US) - before market opens
-
State Street Corporation (STT.US) - before market opens
-
Citizens Financial Groups (CFG.US) - before market opens
This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.
